iShares Nasdaq Biotechnology (IBB) option IV at low end of range
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/20/2026
- Wall Street gains ground on healthcare stocks rally, oil retreat
- Brent slips as Iran president discusses mediation with Pakistan army chief
- Loop Capital downgrades Apple, sees no recovery of cut iPhone shipments
- Wells Fargo says S&P 500 buy signal emerges as investors turn excessively bearish
- ByteDance, Alibaba and Tencent order $35 billion of Nvidia chips: Reuters
Tweet
Share
E-mailiShares Nasdaq Biotechnology (NASDAQ: IBB) 30-day option implied volatility is at 14; compared to its 52-week range of 14 to 35 after President Biden unveils first 10 drugs subject to Medicare price negotiation.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cleveland-Cliffs (CLF) October 23 weekly 14 and 15 calls active as share price up 15.7%
- Lam Research (LRCX) call put ratio 1 call to 1 put into quarter results
- Southwest Airlines (LUV) call put ratio 1.1 calls to 1 put into quarter results
Create E-mail Alert Related Categories
OptionsRelated Entities
OptionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
